Sales Contact

T: +33 1 8362 9036

Industry Publications

"Long Term Care for the Elderly in France, European Comparison", 2011

Industry Report published by Candesic, Deomenos and Epsilon Research

Click here for preview


> Order an Epsilon Market Report (starting at €950) > mail

NB: includes access to the underlying EMAT reports

Alert on Reports Published
Sign up (free) to receive by e-mail updates on EMAT reports published on your preferred sector.


Follow the sector on Twitter

Epsilon Research covers the M&A transactions for the "Health, Pharmaceuticals & Biotechnology" industry [1017 EMAT Reports], which includes:


Our analysts publish transaction multiples reports for private company M&A deals (announced 2004 onwards).

Each report presents detailed information on the deal value, structure and rationale, the target's activity, history and financial information; it includes the calculation of the key historic and current multiples: enterprise value over sales (EV/S), EBITDA (EV/EBITDA), or EBIT (EV/EBIT), P/E and Price to Book. All information sources are systematically given and company financials are carefully verified and restated if needed.


The reports are a unique source of information to have a comparable metric for the valuation of a private company, establish the "market value" of an investment or private equity investment portfolios.


The deal reports are published in Epsilon's EMAT database.
For an example of EMAT report, please click on this link.
If you wish to buy an EMAT Report, and you are not a customer, please contact us.


Recent M&A Deal Reports Published on EMAT

Date Acquirer Target Country Industries Valuation multiples See details
01/10/2021 BICO Group (formerly CELLINK) QInstruments Germany Medical Equipment ** 106707
25/09/2021 Private group led by Siparex Destia Loiret Home Care ** 106691
15/07/2021 Private Group led by Ares Management and Bpifrance Point Vision France Specialist Care * 106658
19/05/2021 Cellink Nanoscribe Germany Medical Equipment ** 105542
23/04/2021 Private Group led by Naxicap Partners Lagarrigue Haute-Garonne Medical Implants or Prostheses Manufacturers * 105539
15/03/2021 DCC Wörner Medizinprodukte Germany Specialised R&W, Medical Supplies * 104383
02/03/2021 Croda International Alban Muller International Eure-Et-Loir Personal Products * 104406
01/03/2021 Hologic Diagenode Belgium Diagnostic Medical Equipment * 104487
28/01/2021 Olympus Quest Photonic Devices Netherlands Medical Equipment * 104418
20/01/2021 Private Group Led by Montagu Private Equity LLP IMV Technologies Orne Medical Supplies, Diagnostic Medical Equipment * 104661
20/01/2021 Private Group led by Qualium Investissement Groupe Clinadent (Yanoal) Hauts-De-Seine Clinics and hospitals, Specialist Care * 106613
30/12/2020 Hologic SOMATEX Medical Technologies Germany Diagnostic Medical Equipment * 104652
11/12/2020 Private Group backed by Ardian Growth and BNP Paribas Développement Proteor Rhône Medical Implants or Prostheses Manufacturers * 106378
14/11/2020 Private Group Led By Cardinal Capital Group Mowlam Healthcare Ireland Care Home * 103484
10/11/2020 Private Group led by Novalpina Capital Laboratoire X.O Hauts-De-Seine Pharmaceuticals, Personal Products * 102982
04/11/2020 Medica Group Global Diagnostics (Ireland) Ireland Clinics and hospitals ** 103410
28/10/2020 Private Group led by Motion Equity Partners Olmix Morbihan Biotechnology, Fertilizers & Pesticides - Manufacturers ** 103240
27/10/2020 Repligen ARTeSYN Biosolutions Ireland Ireland Diagnostic Medical Equipment ** 103381
02/10/2020 Sartorius BIA Separations Slovenia Medical Equipment * 103347
30/09/2020 Atrys Health Instituto Estudios Celulares y Moleculares Spain Medical Diagnostic Laboratory *** 103464
About Epsilon Research

Epsilon Research is an independent research and financial analysis bureau, and the reference source of transaction multiples for the valuation of private companies through its EMAT database.

EMAT Database
Epsilon Multiple Analysis Tool
The Reference Source for Private Company Acquisition Multiples

Test & Subscribe
EMAT Report

► Each EMAT Report includes the detailed analysis of the transaction: deal rationale and structure, target business lines and financials (restated), valuation multiples (calculation and analysis).


► Example of EMAT Report